Neurophysiological and Acute Pharmacological Studies in FXS Patients

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions

Fragile X Syndrome

Interventions

DRUG

Acamprosate

two 666mg pills

DRUG

Lovastatin

two 20mg pills

DRUG

Minocycline

two 135mg pills

DRUG

Placebo

placebo pill

DRUG

Baclofen

one 30mg pill

Trial Locations (1)

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02998151 - Neurophysiological and Acute Pharmacological Studies in FXS Patients | Biotech Hunter | Biotech Hunter